New Key Statistics Module, Z-Score and F-Score
SHSE:688105 Key Ratios
Market Cap ¥ M | 7,632.19 |
Enterprise Value ¥ M | 5,670.28 |
P/E(ttm) | -- |
PE Ratio without NRI | 298.13 |
Forward PE Ratio | 32.90 |
Price/Book | 1.91 |
Price/Sales | 6.16 |
Price/Free Cash Flow | 161.69 |
Price/Owner Earnings | -- |
Payout Ratio % | 19.53 |
Revenue (TTM) ¥ M | 1,285.00 |
EPS (TTM) ¥ | -0.04 |
Beneish M-Score | -2.48 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -125.50 |
EV-to-EBIT | -527.68 |
EV-to-EBITDA | -527.68 |
PEG | -- |
Shares Outstanding M | 400.01 |
Net Margin (%) | -1.18 |
Operating Margin % | -1.34 |
Pre-tax Margin (%) | -3.90 |
Quick Ratio | 2.97 |
Current Ratio | 3.27 |
ROA % (ttm) | -0.26 |
ROE % (ttm) | -0.37 |
ROIC % (ttm) | -0.21 |
Dividend Yield % | 0.52 |
Altman Z-Score | 4.55 |
SHSE:688105 Number of Guru Trades
SHSE:688105 Volume of Guru Trades
Gurus Latest Trades with SHSE:688105
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:688105 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Nanjing Vazyme Biotech Co Ltd Insider Transactions
No Available Data